期刊文献+

中晚期鼻咽癌放化疗前后中医证型与VEGF的相关性研究 被引量:4

Correlation Study on the TCM Syndromes and VEGF in Moderate-Advanced Nasopharyngeal Carcinoma before and after Chemoradiotherapy
下载PDF
导出
摘要 目的研究中晚期鼻咽癌患者同期放化疗前后中医证型和VEGF的相关性。方法对初入院中晚期鼻咽癌患者进行中医辨证分析和VEGF表达检测,对完成放化疗的108例患者再进行中医辨证。分析比较108例患者放化疗前后的中医证型,计算不同证型的VEGF阳性率。结果放化疗前中医证型以瘀血阻络型和痰浊内阻型为主,痰浊内阻证型患者肿瘤组织VEGF阳性率最高;放化疗后阴虚气滞、气血两亏证型明显增多,痰瘀气滞证型患者肿瘤组织VEGF阳性率最高。结论中晚期鼻咽癌患者同期放化疗前中医证型与VEGF表达有一定的相关性,其科学性有待进一步研究。 Objective To study the correlation between TCM syndromes and VEGF in moderate-advanced nasopharyngeal carcinoma before and after concurrent chemoradiotherapy. Methods Newly admitted patients with moderate-advanced nasopharyngeal carcinoma received TCM syndrome differentiation analysis and VEGF expression detection. 108 cases of patients received TCM syndrome differentiation analysis again after completing concurrent chemoradiotherapy. TCM syndromes of 108 cases of patients before and after chemoradiontherapy were analyzed and compared. The VEGF positive rates of different TCM syndromes were counted. Results Before chemoradiontherapy, the main TCM syndromes were static blood blocking collaterals and phlegm retention. Patients with phlegm retention had the highest VEGF positive rate of tumor tissues. After chemoradiontherapy, the syndromes of yin dificiency qi depression significantly increased. Patients with phlegm retention Qi stagnation syndrome had the highest VEGF rate of tumor tissues. Conclusions TCM syndromes in moderate-advanced nasopharyngeal carcinoma before concurrent chemoradiotherapy are related to VEGF expression, and further research about its scientificalness is needed.
作者 李玉齐 潘芸芸 陈斯泽 张帆 姜薇 LI Yuqi;PAN Yunyun;CHEN Size;ZHANG Fan;JIANG Wei(Department of Oncalogy,the First Affiliated Hospital of Guangdong Pharmaceutical University,Guangzhou 510080,China)
出处 《临床医学工程》 2018年第9期1163-1164,共2页 Clinical Medicine & Engineering
基金 广东省中医药管理局项目(项目编号:20152156)
关键词 鼻咽癌 中医证型 同期放化疗 VEGF Nasopharyngeal carcinoma TCM syndrome Concurrent chemoradiotherapy VEGF
  • 相关文献

参考文献2

二级参考文献13

  • 1梅全喜,孙雪颖,高玉桥,周小军.中医药防治鼻咽癌的研究进展[J].中国药业,2007,16(4):28-29. 被引量:12
  • 2Yashiji H, Gomez DE, Shibuya M, et al. Expression of VEGF,its receptor and other angiogenic factors in human breast cancer[J]. Cancer Res, 1996, 56: 2013-2016.
  • 3lnoue K , Oreki Y, Suganuma T , et al. Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma[ J]. Cancer, 1997, 79:206.
  • 4Grunstein J, Roberts WG, Mathieu-Costello O,et al. Tumor-derived expression of vascular endothelial growth factor is a critical factor in tumor expansion and vascular function [ J ]. Cancer Res,1999, 59: 1592-1598.
  • 5Uiwa T, Takebayashi Y, Akiba S, et al. Expression of thymidine phosphorlase and vascular endothelial cell growth factor in human head and neck squamous cell carcinoma and their different characteristics[J].Cancer, 1999, 85: 960-969.
  • 6Wakisaka N, Wen QH, Yoshizaki T, et al. Association of vascular endothelial growth factor expression with angiogenesis and lymph node metastasis in nasopharyngeal carcinoma[ J]. Laryngoscope, 1999, 109: 810-814.
  • 7lnoue K, Ozeki Y, Suganuma T, et al. Vasular endothelial growth factor expression in primary esophageal squamous cell carcinoma[J]. Cancer, 1997, 79: 206-213.
  • 8Boocock CA, Chamock Jones PS, Sharkey AM, et al. Expression of VEGF and its receptors fit and KDR in ovarian carcinoma[ J].J Natl Cancer Inst,1995, 87 : 506.
  • 9Veikkola T, Alitalo K. VEGFs, receptors and angiogenesis[ J].Semin Cancer Biol, 1999, 9: 211-220.
  • 10Hartmann A, Kunz M, kutlin S, et cd. Hypoxla induced up-regulation of angiogenin in human malignant melanoma[ J ]. Cancer Res, 1999, 59: 1578-1583.

共引文献19

同被引文献59

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部